0001213900-19-016514.txt : 20190822
0001213900-19-016514.hdr.sgml : 20190822
20190822163033
ACCESSION NUMBER: 0001213900-19-016514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190820
FILED AS OF DATE: 20190822
DATE AS OF CHANGE: 20190822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Juda Scott
CENTRAL INDEX KEY: 0001767084
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 191046392
MAIL ADDRESS:
STREET 1: 325 N. LARCHMONT BLVD, SUITE 375
CITY: LOS ANGELES
STATE: CA
ZIP: 90004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
ownership.xml
X0306
4
2019-08-20
0
0001711754
Inmune Bio, Inc.
INMB
0001767084
Juda Scott
C/O INMUNE BIO INC.,
1200 PROSPECT STREET, SUITE 525
LA JOLLA
CA
92037
1
0
0
0
Common Stock
2019-08-20
4
P
0
2500
6.00
A
25000
D
Common Stock
2019-08-21
4
P
0
2500
6.00
A
27500
D
The Reporting Person purchased 2,500 shares of the Issuer's common stock in an open market transaction on August 20, 2019 and 2,5000 shares of the Issuer's common stock in an open market transaction on August 21, 2019.
The Reporting Person's shares are held by Fossick Capital LP ("Fossick"), a limited partnership. The Reporting Person holds all voting and dispositive control over the Issuer's shares of common stock held by Fossick.
/s/ Scott Juda
2019-08-22